Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $50.7M | $30.7M | $71.4M | $44.5M | $66.2M | $58.8M | $86.0M | $66.8M | $127.3M | $108.8M | $150.2M | $170.8M | $144.8M | $197.6M | $178.8M | $199.8M | $213.4M | $250.3M | $221.9M | $239.4M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Prestige Consumer Healthcare Inc.'s last 12-month Free Cash Flow is $254.6M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Prestige Consumer Healthcare Inc.'s Free Cash Flow growth was 18.0%. The average annual Free Cash Flow growth rates for Prestige Consumer Healthcare Inc. have been 6.1% over the past three years, 6.5% over the past five years.
Over the last year, Prestige Consumer Healthcare Inc.'s Free Cash Flow growth was 18.0%, which is higher than industry growth of (1.0%). It indicates that Prestige Consumer Healthcare Inc.'s Free Cash Flow growth is Good.